PoliticsHigh · factual reporting (4 of 5)Outlet ratings by Media Bias/Fact Check 
F.D.A. Rejects Closely Watched Lung Cancer Drug From China
Rebecca Robbins·The New York Times·November 15, 2026

The treatment, called ivonescimab, has become a symbol of China’s rise in drug development.
Read the full story at The New York Times →